VJHemOnc is committed to improving our service to you

SOHO 2020 | Challenges in CAR T-cell therapy

VJHemOnc is committed to improving our service to you

Renier J. Brentjens

Renier J. Brentjens, MD, PhD, of Memorial Sloan-Kettering Cancer Center, New York, NY, outlines the major challenges in CAR T-cell therapies including remission and relapse rate, cost, as well as mitigating associated toxicities. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter